SI3082798T1 - Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti - Google Patents

Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti

Info

Publication number
SI3082798T1
SI3082798T1 SI201431852T SI201431852T SI3082798T1 SI 3082798 T1 SI3082798 T1 SI 3082798T1 SI 201431852 T SI201431852 T SI 201431852T SI 201431852 T SI201431852 T SI 201431852T SI 3082798 T1 SI3082798 T1 SI 3082798T1
Authority
SI
Slovenia
Prior art keywords
hyperactivity
treatment
attention deficit
benzodioxol derivatives
benzodioxol
Prior art date
Application number
SI201431852T
Other languages
English (en)
Inventor
Marc Verleye
Veronique Riban
Guern Marie-Emmanuelle Le
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of SI3082798T1 publication Critical patent/SI3082798T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4458Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
SI201431852T 2013-12-18 2014-12-17 Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti SI3082798T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13306768.6A EP2886116A1 (en) 2013-12-18 2013-12-18 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
EP14828152.0A EP3082798B1 (en) 2013-12-18 2014-12-17 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity
PCT/EP2014/078345 WO2015091718A1 (en) 2013-12-18 2014-12-17 Benzodioxol derivatives for use in the treatment of attention deficit and/or hyperactivity

Publications (1)

Publication Number Publication Date
SI3082798T1 true SI3082798T1 (sl) 2021-09-30

Family

ID=49883008

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431852T SI3082798T1 (sl) 2013-12-18 2014-12-17 Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti

Country Status (11)

Country Link
US (1) US20160331723A1 (sl)
EP (2) EP2886116A1 (sl)
JP (1) JP6585598B2 (sl)
CA (1) CA2933730C (sl)
DK (1) DK3082798T3 (sl)
ES (1) ES2879951T3 (sl)
HU (1) HUE054891T2 (sl)
PL (1) PL3082798T3 (sl)
PT (1) PT3082798T (sl)
SI (1) SI3082798T1 (sl)
WO (1) WO2015091718A1 (sl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795893A (fr) 1972-02-28 1973-06-18 Unicler Derives de (methylene dioxy-3,4 phenyl)-1 dimethyl-4,4 pentene-1, leur preparation et leur application en therrapeutique
FR2253505A2 (en) * 1973-12-10 1975-07-04 Unicler Alpha ethylenic alcohol and ketone derivs of pinacoline - modifiers of hexobarbital narcosis and anticonvulsants
FR2253503A2 (en) * 1973-12-10 1975-07-04 Unicler Ethylenic piperonal alcohols and ketones - anxiolytics, antidepressants, hypnotics and tranquillisers
CA2508731A1 (en) * 2003-02-19 2004-09-02 Neurogen Corporation Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
JP2007523109A (ja) * 2004-02-18 2007-08-16 エフ.ホフマン−ラ ロシュ アーゲー 複素環式Gaba−Aサブタイプ選択的レセプターモジュレーター
WO2008095221A1 (en) * 2007-02-07 2008-08-14 Gosforth Centre (Holdings) Pty Ltd Treatment of adhd
EP2331088A4 (en) * 2008-08-06 2011-10-12 Gosforth Ct Holdings Pty Ltd COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
US20100144863A1 (en) * 2008-12-08 2010-06-10 Bernard Hublot Compounds and methods for treating autism spectrum disorders
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
WO2011057199A1 (en) * 2009-11-06 2011-05-12 Adenios, Inc. Compositions for treating cns disorders
WO2012018635A2 (en) * 2010-07-26 2012-02-09 Neurotherapeutics Pharma, Inc. Arylsulfonamide derivatives, compositions, and methods of use

Also Published As

Publication number Publication date
ES2879951T3 (es) 2021-11-23
PT3082798T (pt) 2021-07-16
DK3082798T3 (da) 2021-07-19
HUE054891T2 (hu) 2021-10-28
JP2016540815A (ja) 2016-12-28
EP3082798A1 (en) 2016-10-26
JP6585598B2 (ja) 2019-10-02
CA2933730A1 (en) 2015-06-25
EP2886116A1 (en) 2015-06-24
PL3082798T3 (pl) 2021-11-02
CA2933730C (en) 2022-06-28
WO2015091718A1 (en) 2015-06-25
US20160331723A1 (en) 2016-11-17
EP3082798B1 (en) 2021-05-05

Similar Documents

Publication Publication Date Title
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
GB2513167B (en) Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
IL242483B (en) Preparations containing omomyc and their use for cancer treatment
EP3072517A4 (en) Use of ginsenoside-rg3 in preparing medicine for preventing or/and treating dementia and medicine
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
GB2509710B (en) Photobioreactor and its use in waste water treatment
HRP20190219T1 (hr) Spojevi za tretman pretilosti i postupci za njihovu uporabu
PL2872176T3 (pl) Karboranyloporfiryny do stosowania w leczeniu raka
GB201308753D0 (en) Compounds and their use in therapy
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
SI3082798T1 (sl) Benzodioksolni derivati za uporabo pri zdravljenju pomanjkanja pozornosti in/ali hiperaktivnosti
HUE047636T2 (hu) Arginin csontízületi gyulladás kezelésében és/vagy megelõzésében történõ alkalmazásra
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB201314784D0 (en) Method and homeopathic remedy for treatment of the attention deficit hyperactivity disorder in children
GB201308217D0 (en) Compounds and their use in therapy